US Pharma MarketingThe post Roche secures CE Mark for Elecsys test to detect tuberculosis appeared first on Medical Device Network.
Roche secures CE Mark for Elecsys test to detect tuberculosis
Roche has secured the CE Mark for its Elecsys IGRA TB blood-based test designed to detect latent tuberculosis infection in routine laboratory settings. The Elecsys IGRA TB test runs on Roche’s cobas immunoassay systems. In confirmed TB patients, the test showed 100% relative sensitivity and 95.32% specificity in a low-risk cohort. Credit: NMK-Studio / Shutterstock.com. Roche has secured the CE Mark for its Elecsys Interferon Gamma Release Assay (IGRA) TB blood-based test designed to detect latent tuberculosis infection (TBI) in routine laboratory settings. The blood-based test can deliver results in under 24 hours, with the assay itself requiring just 19…
Roche has secured the CE Mark for its Elecsys IGRA TB blood-based test designed to detect latent tuberculosis infection in routine laboratory settings.
Source: Medical Device Network